How to Buy Icad Stock
Icad Inc
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy.
Icad stock last closed at $2.37, down 1.25% from the previous day, and has decreased 54.77% in one year. It has underperformed other stocks in the Health Information Services industry by 0.2 percentage points. Icad stock is currently +54.9% from its 52-week low of $1.53, and -61.15% from its 52-week high of $6.10.
As of Feb 3, 2023, there are 25.45M ICAD shares outstanding. The market cap of ICAD is $60.31M. In the past 24 hours, 92,595 ICAD shares were traded.
How to Buy Icad Stock
Not sure how to invest in Icad stock? Here's how.
- Choose where to buy Icad stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you decide where to buy Icad stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit money your investment account: Pick your payment method and add your information.
- Analyze Icad stock: The Icad ticker symbol is ICAD. Is Icad stock a good investment? Should you buy shares of ICAD? How do ICAD's underlying business fundamentals look? Do top analysts think Icad is a good buy? Why has ICAD's stock price moved recently? (Hint: Our stock market research website can help you understand if ICAD is a good stock to buy).
- Place your ICAD trade: Decide if you will purchase ICAD shares at the current market price or use a limit order to buy ICAD stock at a specific price.
- Get key alerts regarding your ICAD investment: Create a watchlist to keep tabs on your investment in Icad shares.
Step 1: Choose where to buy Icad stock
You need a brokerage account in order to access the NASDAQ market and buy ICAD shares.
Our favorite brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Utilities, New York to Hong Kong — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked your brokerage, you'll need to fill out some personal information so you can buy ICAD stock today.
How to Open a New Investment Account on eToro
- Click here to get started.
- Enter your personal details to create a new trading account.
- Submit your details by hitting the "Create Account" button.
Step 3: Deposit money your investment account
Now that you've opened your account on the stocks app, you need to deposit funds:
Check out the walkthrough below for more details transferring money into your new investment account.
Step 4: Analyze Icad stock
Once you have identified the best place to buy Icad stock, it's critical to research their stock before you invest, so you actually understand the risk as well as the opportunity.
Icad quick stats
Icad Due Diligence Checks
WallStreetZen was built to help part-time investors perform better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on ICAD's stock page.
Is ICAD stock overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge ICAD's intrinsic value.
Using relative valuations measures:
- ICAD could be undervalued based on its P/B ratio of 1.6x, relative to Health Information Services industry P/B ratio of 3.02x
You can access additional valuation research on ICAD's stock here.
A quick look at ICAD Financials
Positive Financial Indicators:
- There are more short-term assets than short-term liabilities on the ICAD balance sheet.
- There are more short-term assets than long-term liabilities on the ICAD balance sheet.
- ICAD has $24.59M in cash and short term investments. This is sufficient to cover its annual cash burn of $11.70M.
- Total ICAD debt is lower than 5 years ago, relative to shareholder equity.
- ICAD has cash burn of 11699000. It has sufficient cash and short-term investments to cover this for at least one year.
Negative Financial Indicators:
- ICAD has a relatively high debt to equity ratio of 0.47.
- ICAD profit margin has gone down from -24% to -50.3% in the past year.
Do analysts think it's a good time to buy ICAD stock
Out of 3 sell side analysts who track ICAD, the consensus analyst rating on ICAD is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Most Recent ICAD Analyst Forecasts
David Turkaly, a bottom 24% analyst from JMP Securities maintains ICAD with a buy rating and lowers their ICAD price target from $13.00 to $7.00, on Sep 1, 2022.
Frank Takkinen, a bottom 2% analyst from Lake Street maintains ICAD with a strong buy rating and lowers their ICAD price target from $13.00 to $8.00, on Aug 11, 2022.
Marie Thibault, a top 4% analyst from BTIG maintains ICAD with a strong buy rating and lowers their ICAD price target from $10.00 to $8.00, on Jun 24, 2022.
You can dig deeper into what analysts are projecting on the Icad stock forecast page.
ICAD Technicals
How are ICAD Revenues/Earnings doing?
Last year, ICAD revenue was $29.26M. Over the last five year, ICAD's revenue has gone up by 1.53% per year. This was slower than the Health Information Services industry average of 44.69%.
Learn more about ICAD's earnings and revenue performance here.
What are ICAD insiders up to?
In the past year, executives and large shareholders at ICAD have sold more shares than they have bought.
Jonathan Go, Chief Technology Officer of ICAD, was the latest ICAD insider to buy. They bought $102,150.00 worth of ICAD shares on Sep 12, 2022.
Dig into more about who owns ICAD shares here.
Can I get consistent income from ICAD stock?
No, Icad doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Place your ICAD trade
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally the easiest way to buy. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount, place a limit order.
Hit the Open button and your broker will execute the order.
If you need more info about investing in stocks on eToro, click the helpful video below:
Step 6: Get key alerts regarding your ICAD investment
Now that you own some ICAD shares, you'll want to keep up with your investment.
Create a watchlist to keep track of your ICAD stock.
ICAD Feed
How to Buy Stock in Icad
To summarize, here are the 6 steps to buy Icad stock:
- Choose where to buy Icad stock
- Open a brokerage account
- Deposit money your investment account
- Analyze Icad stock
- Place your ICAD trade
- Get key alerts regarding your ICAD investment
If you require a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get the latest scoop on your new investment in Icad, hit the button below to create your watchlist.
Other Content You Might Find Useful
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.